UTI Asset Management Company Limited has confirmed that no new encumbrance has been created on its shares during the financial year ending March 31, 2026. The declaration, submitted to the stock exchanges, ensures compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This disclosure provides shareholders with assurance regarding the unencumbered status of the company's equity for the specified period.

The declaration was made by Life Insurance Corporation of India, which holds a significant stake in the asset manager. The confirmation states that no encumbrance has been made directly or indirectly, other than those already disclosed to the exchanges during FY26. The filing was addressed to the National Stock Exchange of India Limited and BSE Limited.

Regulatory Compliance

The submission was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires entities to disclose any encumbrance on shares to ensure transparency in the market. The declaration was signed by S. K. Srivastava, Executive Director (Investment: Back Office) of Life Insurance Corporation of India.

Key Disclosure Details

UTI Asset Management Company Limited has scheduled a group meeting with analysts and institutional investors on June 11, 2026, at its Corporate Office in BKC, Mumbai. The interaction is set to take place at 1600 hrs IST and will be conducted in person with the company's senior management.

The disclosure was made pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company specified that no unpublished price sensitive information (UPSI) will be shared during the meeting.

The meeting will include four institutional participants. The list of attendees includes Square 64 Capital Advisors LLP, Dand Family Office, White Stone Financial Advisors Private Limited, and Credential Investments.

Meeting Schedule

The company noted that the date of the meeting is subject to change. Arvind Patkar, Company Secretary and Compliance Officer, signed the disclosure on behalf of UTI AMC.